PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEvraz Regulatory News (EVR)

  • This share is currently suspended. It was suspended at a price of 82.52

Share Price Information for Evraz (EVR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 82.52
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 82.52
EVR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on COVID-19

16 Apr 2020 14:00

RNS Number : 9171J
Evraz Plc
16 April 2020
 

Update on COVID-19

 

16 April 2020 - EVRAZ plc ("EVRAZ or the "Group") today announces an update on the impact of COVID-19 on its business.

Group focus and priorities

The Group is closely monitoring the development of the COVID-19 pandemic and its impact on our employees, our operations and the broader stakeholder base. EVRAZ's immediate focus is on doing everything in its power to protect the lives and health of our employees and minimise the negative impact on our facilities and the communities in which we operate.

During and since March 2020, in response to the coronavirus pandemic the Group has introduced additional safety measures to protect its people and ensure continued operations.

These include:

· Significant reduction of domestic and cancellation of overseas business travel;

· Two-week isolation, with full salary, for all employees returning from trips abroad, either personal or work-related;

· Enabling remote working, provision of additional personal protection equipment for employees who must come to work, including eye protectors, respirators and gloves;

· Installation of thermal imaging devices and pyrometers at the entrances to our facilities to monitor people's temperatures;

· Elimination to the extent possible of large gatherings (with social distancing when they must take place), and cancellation of all major corporate, sporting and entertainment events;

· Increase of supplies of antiseptic and disinfectant products in communal areas, regular sanitation of facilities and transport;

· Campaigns to raise awareness among employees and contractors on behavioural features, social distancing and personal protection.

The Group is monitoring the spread of coronavirus and working with healthcare facilities and insurance organisations to take proactive decisions aimed at safeguarding its employees and their families. Currently there are no confirmed COVID-19 cases in EVRAZ.

Update on our operations and outlook 

The Group remains closely focused on its operations, including logistics, supply and technological processes. At present, EVRAZ is facing no significant issues with the production or supply of raw materials and other goods. Shipments continue, and raw material deliveries to enterprises are stable.

However, in the near term, we expect domestic steel demand to fall due to the significant economic down-turn that the restrictions imposed due to COVID-2019 are causing worldwide, including in Russia. This will, no doubt, affect firstly our construction products sales and then our railway products sales, to a slightly lesser extent.

We expect the impact on exports to be less significant. This is due to the recent rouble devaluation and EVRAZ's ability to redirect steel from domestic sales to export markets.

While the impact on the Group has been limited so far, we are likely to experience challenges in the near term. While our enterprises have been operating at full capacity, the situation is likely to be more complex in May and June. In the light of this, EVRAZ is working on a comprehensive package of optimisation measures that we expect to partially mitigate these negative effects.

Our financial position

The Group remains well capitalised with a strong liquidity cushion.

As at 31 December 2019, our net debt amounted to US$3,445 million. This reflected cash of US$1,423 million. Short-term loans and the current portion of long-term loans stood at US$140 million. Total scheduled debt maturities during 2020 will amount to no more thanUS$52 million.

In March 2020, EVRAZ paid interim dividends to its shareholders amounting to US$580.8 million, US$0.40 per share.

In addition, also in March 2020, EVRAZ signed a US$750 million 5-year committed syndicated unsecured credit facility. This facility was arranged and fully underwritten by a group of 10 international banks and is available for drawing until 18 March 2021. The proceeds of the facility will be used for general corporate purposes, including refinancing of the public debt maturities upcoming in Q1 2021.  

In March and April, the Group also added RUB20 billion to its cash cushion by utilisation of its committed and uncommitted credit lines in Russia, due 2023.

The first sizeable maturities are due in Q1 2021 which should be comfortably covered by our existing cash balances and committed credit facilities.

Despite Covid-19 related challenges and market downturns, EVRAZ remains committed to its long-term strategic goals, sustainability principles and high standards of corporate governance and control.

 

For more information, please contact:

 

Investor Relations

Tel: +7 495 232 1370

Email: ir@evraz.com

 

Media Relations

Tel: +7 495 937 6871

Email: media@evraz.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDGPUAGCUPUGPQ
Date   Source Headline
16th Dec 20164:40 pmRNSSecond Price Monitoring Extn
16th Dec 20164:35 pmRNSPrice Monitoring Extension
14th Nov 20167:00 amRNSEVRAZ announces the appointment of a new CFO
18th Oct 20168:30 amRNSEVRAZ plc holds Investor Day
18th Oct 20167:00 amRNSEVRAZ Q3 2016 PRODUCTION REPORT
18th Aug 20167:00 amRNSHalf-year Report
16th Aug 20164:48 pmRNSReport on payments to governments 2015 (amended)
11th Aug 20162:49 pmRNSNOTICE OF H1 2016 RESULTS
19th Jul 20167:00 amRNSEVRAZ Q2 2016 PRODUCTION REPORT
14th Jul 20163:37 pmRNSDirector/PDMR Shareholding
14th Jul 20167:29 amRNSEVRAZ Builds a New Blast Furnace at NTMK
5th Jul 20165:12 pmRNSEVRAZ plc announces senior management changes
24th Jun 20162:47 pmRNSReport on payments to goverments 2015
16th Jun 20164:41 pmRNSResults of the Annual General Meeting
10th Jun 201610:54 amRNSEVRAZ priced $500 million note issue
9th Jun 20166:00 pmRNSDirector/PDMR Shareholding
7th Jun 20166:00 pmRNSHolding(s) in Company
31st May 20166:00 pmRNSDirector/PDMR Shareholding
31st May 20162:00 pmRNSTotal Voting Rights
26th May 20165:10 pmRNSDirector/PDMR Shareholding
26th May 20163:00 pmRNSDirector/PDMR Shareholding
20th May 20162:50 pmRNSTransfer of shares out of treasury, Voting rights
17th May 20167:00 amRNSNotice of 2016 AGM
22nd Apr 20167:16 amRNSDirector/PDMR Shareholding
20th Apr 20167:00 amRNSQ1 2016 PRODUCTION REPORT
18th Mar 20163:09 pmRNSEVRAZ Priced 15 Billion Rouble Bond Issue
15th Mar 20167:15 amRNSDirectorate Change
15th Mar 20167:00 amRNSAnnual Financial Report
4th Mar 201611:30 amRNSNOTICE OF FY 2015 RESULTS
19th Jan 201611:22 amRNSQ4 and FY 2015 production report
14th Dec 201512:13 pmRNSEVRAZ priced $750 million note issue
9th Nov 201510:25 amRNSResult of Tender Offer
5th Nov 20159:40 amRNSStatement re. EVRAZ Highveld
16th Oct 20157:00 amRNS3rd Quarter 2015 Production Results
8th Oct 20159:46 amRNSHolding(s) in Company
27th Aug 20157:01 amRNSHalf Yearly Report
19th Aug 20153:08 pmRNSNotice of H1 2015 Results
31st Jul 201512:59 pmRNSDirector Declaration
17th Jul 20157:00 amRNSEVRAZ Q2 2015 production results
15th Jul 201512:00 pmRNSEVRAZ received a loan from ALFA-BANK
30th Jun 201512:43 pmRNSTotal Voting Rights
25th Jun 20155:08 pmRNSEVRAZ Priced 15 Billion Rouble Bond Issue
24th Jun 20156:00 pmRNSDirector/PDMR Shareholding
18th Jun 20152:12 pmRNSResults of the Annual General Meeting
17th Jun 20158:28 amRNSEVRAZ plc holds Investor Day
16th Jun 20153:13 pmRNSChanges to the Board Committees
8th Jun 20158:29 amRNSDirector/PDMR Shareholding
4th Jun 20156:11 pmRNSDirector/PDMR Shareholding
4th Jun 20157:14 amRNSDirector/PDMR Shareholding
2nd Jun 20153:34 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.